← Eichor
Study identifier: NCT06830759 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

Condition: Diffuse Large B-cell Lymphoma · Follicular Lymphoma  ·  Sponsor: AbbVie

PhaseN/A
Planned participants700
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Diffuse large B-cell lymphoma (DLBCL) is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections) and the most common type of non-Hodgkin lymphoma. Follicular Lymphoma (FL) is a slow-growing type of non-Hodgkin lymphoma. The purpose of this study is to assess the real-world effectiveness of subcutaneous epcoritamab in adult participants with advanced DLBCL and FL. Epcoritamab is an investigational drug being developed for treating participants with DLBCL and FL. Approximately 700 participants will be enrolled in approximately 80 sites across 12-20 countries globally. Participants will receive epcoritamab as prescribed by their physician in accordance with local country label. Participants will be followed for up to 3 years. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.

This description comes directly from the study's public registry record.

Talk to the study team

Rebekah Taylor  ·  (847) 937-8000  ·  rebekah.taylor@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (73)

Hospital Britanico de Buenos Aires /ID# 274419Ciudad Autonoma de Buenos Aire, Buenos Aires, ArgentinaRecruiting
Hospital Universitario Austral /ID# 274393Pilar, Buenos Aires, ArgentinaRecruiting
Instituto Alexander Fleming /ID# 277284Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., ArgentinaRecruiting
Hospital Privado Universitario De Córdoba /ID# 274457Córdoba, Córdoba Province, ArgentinaRecruiting
Hospital Italiano de Buenos Aires /ID# 274418Buenos Aires, ArgentinaRecruiting
Fundacion Argentina contra la Leucemia (FUNDALEU) /ID# 274390Buenos Aires, ArgentinaRecruiting
Nepean Cancer Centre, Nepean Hospital /ID# 277782Kingswood, New South Wales, AustraliaRecruiting
Calvary Mater Newcastle /ID# 277783Waratah, New South Wales, AustraliaRecruiting
Cabrini Hospital Malvern /ID# 277780Malvern, Victoria, AustraliaRecruiting
Krankenhaus Der Barmherzigen Brueder Graz /ID# 273288Graz, Styria, AustriaRecruiting
Landeskrankenhaus Hochsteiermark, Standort Leoben /ID# 273266Leoben, Styria, AustriaRecruiting
Algemeen Ziekenhuis klina /ID# 273405Brasschaat, Antwerpen, BelgiumRecruiting

+ 61 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06830759